User profiles for F Martinez

Fernando Martinez

- Verified email at med.cornell.edu - Cited by 134079

Fernando D. Martinez

- Verified email at email.arizona.edu - Cited by 91748

Fernando O Martinez Estrada

- Verified email at surrey.ac.uk - Cited by 33246

Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary

…, PJ Barnes, LM Fabbri, FJ Martinez… - American journal of …, 2013 - atsjournals.org
Chronic obstructive pulmonary disease (COPD) is a global health problem, and since 2001,
the Global Initiative for Chronic Obstructive Lung Disease (GOLD) has published its strategy …

[HTML][HTML] The M1 and M2 paradigm of macrophage activation: time for reassessment

FO Martinez, S Gordon - F1000prime reports, 2014 - ncbi.nlm.nih.gov
Macrophages are endowed with a variety of receptors for lineage-determining growth factors,
T helper (Th) cell cytokines, and B cell, host, and microbial products. In tissues, …

[PDF][PDF] Alternative activation of macrophages: mechanism and functions

S Gordon, FO Martinez - Immunity, 2010 - cell.com
The concept of an alternative pathway of macrophage activation has stimulated interest in its
definition, mechanism, and functional significance in homeostasis and disease. We assess …

Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper

…, J Heffner, S Lareau, P Meek, F Martinez… - European …, 2004 - Eur Respiratory Soc
Background The Standards for the Diagnosis and Treatment of Patients with COPD
document 2004 updates the position papers on chronic obstructive pulmonary disease (COPD) …

International Study of Asthma and Allergies in Childhood (ISAAC): rationale and methods

…, R Beasley, J Crane, F Martinez… - European respiratory …, 1995 - Eur Respiratory Soc
The aetiology of asthma and allergic disease remains poorly understood, despite considerable
research. The International Study of Asthma and Allergies in Childhood (ISAAC), was …

[HTML][HTML] Dapagliflozin in heart failure with mildly reduced or preserved ejection fraction

…, MN Kosiborod, CSP Lam, F Martinez… - … England Journal of …, 2022 - Mass Medical Soc
Background Sodium–glucose cotransporter 2 (SGLT2) inhibitors reduce the risk of hospitalization
for heart failure and cardiovascular death among patients with chronic heart failure …

An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management

G Raghu, HR Collard, JJ Egan, FJ Martinez… - American journal of …, 2011 - atsjournals.org
This document is an international evidence-based guideline on the diagnosis and management
of idiopathic pulmonary fibrosis, and is a collaborative effort of the American Thoracic …

[HTML][HTML] Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction

…, F Zannad, J Neaton, F Martinez… - … England Journal of …, 2003 - Mass Medical Soc
Background Aldosterone blockade reduces mortality and morbidity among patients with
severe heart failure. We conducted a double-blind, placebo-controlled study evaluating the …

[HTML][HTML] Dapagliflozin in patients with heart failure and reduced ejection fraction

…, L Køber, MN Kosiborod, FA Martinez… - … England Journal of …, 2019 - Mass Medical Soc
Background In patients with type 2 diabetes, inhibitors of sodium–glucose cotransporter 2 (SGLT2)
reduce the risk of a first hospitalization for heart failure, possibly through glucose-…

Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report. GOLD executive summary

CF Vogelmeier, GJ Criner, FJ Martinez… - American journal of …, 2017 - atsjournals.org
This Executive Summary of the Global Strategy for the Diagnosis, Management, and Prevention
of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2017 report …